xCystence Bio
Biotechnology Research
Developing new approaches to treating Polycystic Kidney Disease
About us
xCystence Bio is developing new treatments for Polycystic Kidney Disease (PKD). PKD affects >1/1000 people and leads to a progressive decline in renal function. It often results in organ failure requiring dialysis or kidney transplant. Current therapies for treating PKD are limited. At xCystence Bio we are developing approaches to prevent the formation of new cysts and the growth of existing ones. We aim to provide a better quality of life for those affected by the disease.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held